Xias Bio

Replacing Animal Proteins

Xias Bio is active in the sustainable manufacturing space based in United Kingdom, founded in 2020.

Profile

Xias Bio is a biotechnology company focused on developing sustainable, animal-free protein alternatives with excellent product-market fit. The company engineers high-performance recombinant proteins that supersede animal-derived proteins such as collagen, keratin, and elastin. Using its proprietary LiteProtein™ platform, Xias Bio creates multifunctional proteins and peptide complexes that combine the functions of several conventional proteins into a single raw ingredient. These products are produced through fermentation, making them scalable, consistent, and environmentally friendly. Xias Bio’s technology aims to reduce the environmental and ethical impacts associated with legacy sources while offering manufacturers functional, cost-effective ingredients. The company’s initial commercial focus is on cosmetics and personal care, with plans to expand into other sectors their customers operate including biotechnology, agriculture, and potentially pharmaceuticals. Rather than selling directly to consumers, Xias Bio primarily licenses its protein designs to ingredient manufacturers and industry partners.

Within the sustainable manufacturing space, the company focuses on its core offering rather than a broad product line.

United Kingdom is where the company is located.

Directory data places it at the SOSV portfolio company stage.

Its team size is recorded as 2-10 employees.

Website: www.xiasbio.com